Identification of the Third Case of PSEN1 Tyr389His Variant in Early-Onset Alzheimer's Disease in Korea.
Kyu Hwan ShimSangjoon KangSeong Soo Alexander AnMin-Ju KangPublished in: International journal of molecular sciences (2022)
Amyloid precursor protein ( APP ), presenilin 1 ( PSEN1 ), and presenilin 2 ( PSEN2 ) are associated with autosomal-dominant early-onset Alzheimer's disease (AD). Most mutations have been identified in the PSEN1 gene. We discovered a PSEN1 mutation (Tyr389His) in a Korean patient with early-onset AD who presented memory decline at 41 years of age followed by language, memory, and visuospatial dysfunctions. As this is the third such patient identified in Korea, this mutation may be involved in AD pathogenesis, suggesting that routine screening is necessary in this population. Altered intra-molecular interactions with the mutated amino acid may result in the destabilization of γ-secretase. In the future, a panel incorporating genes with relatively high-frequency rare variants, along with the APOE4 gene, may predict the onset of AD and facilitate customized treatment.
Keyphrases
- early onset
- high frequency
- late onset
- working memory
- copy number
- cognitive decline
- amino acid
- genome wide
- transcranial magnetic stimulation
- genome wide identification
- case report
- bioinformatics analysis
- autism spectrum disorder
- high fat diet
- type diabetes
- genome wide analysis
- dna methylation
- mild cognitive impairment
- skeletal muscle
- adipose tissue
- current status
- metabolic syndrome
- binding protein
- smoking cessation